Methods and compositions for inhibiting diseases of the central nervous system
View Patent ↗Methods and compositions for treating central nervous system diseases and disorders are disclosed. In a particular embodiment, compositions comprising a nitrated alpha synuclein peptide are provided. The composition may further comprise an adjuvant that stimulates regulatory T cells and/or at least one pharmaceutically acceptable carrier.
1. A composition comprising: a) an alpha-synuclein peptide, wherein said alpha-synuclein peptide consists of SEQ ID NO: 11, wherein said alpha-synuclein peptide is amidated or acetylated, and wherein said alpha-synuclein peptide comprises at least one nitrotyrosine; and b) a pharmaceutically acceptable carrier.
2. A composition comprising: a) an alpha-synuclein peptide, wherein said alpha-synuclein peptide consists of SEQ ID NO: 3, wherein said alpha-synuclein peptide is amidated or acetylated, and wherein said alpha-synuclein peptide comprises at least one nitrotyrosine; and b) a pharmaceutically acceptable carrier.